•
Sep 30, 2024
•
/

CureVac Q3 2024 Earnings Report

Total Revenue
€485M
Previous year: €16.9M
+2763.2%
EPS
-€0.214
Previous year: -€0.227
-5.4%
Gross Profit
€460M
Previous year: -€13.2M
-3587.5%
Cash and Equivalents
€549M
Previous year: €464M
+18.4%
Free Cash Flow
€340M
Previous year: -€73.4M
-563.9%
Total Assets
€851M
Previous year: €842M
+1.1%

CureVac

CureVac